Q1 2023 VistaGen Therapeutics Inc Earnings Call Transcript
Welcome to the VistaGen Therapeutics First Quarter Fiscal Year 2023 Results Conference Call. (Operator Instructions)
I'll now turn the call over to your host, Mark Flather, Vice President of Investor Relations. Mr. Flather, you may begin.
Thank you, Erica. Hello, and welcome to VistaGen's conference call covering our first quarter of fiscal year 2023 financial results and business update. I'm Mark Flather, Vice President of Investor Relations at VistaGen. Thank you for joining us today, and welcome to our stockholders, analysts and anyone taking an interest in VistaGen.
Joining me today are Shawn Singh, our Chief Executive Officer; and Jerry Dotson, our Chief Financial Officer. The format for this call will consist of prepared remarks from management, followed by a brief opportunity for questions. This call is being webcasted and will be available for replay. The link to access the replay can be found in the Investors IR Calendar section of our website, vistagen.com.
On today's call, we will make forward-looking statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |